Načítá se...
Oncogenic and drug sensitive NTRK1 rearrangements in lung cancer
We identified novel gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the TRKA receptor. Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic. Treatment of cells expressing NTRK1 fusions with inhibi...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2013
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3823836/ https://ncbi.nlm.nih.gov/pubmed/24162815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.3352 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|